Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01947140
Title Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (PDX+Romi)
Acronym PDX+Romi
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enrica Marchi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.